RA Capital-backed Summation Bio is “terminating operations” next month; Abbott sues former scientist over alleged trade-secret theft; FDA puts clinical hold on PepGen’s myotonic dystrophy type 1 drug.
Moderna says it is looking for opportunities in China after confirming that it registered a legal entity there; Walgreens cuts 10% of its corporate workforce.